📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The HLA-A*31:01 allele: influence on carbamazepine treatment. (2017)

First Author: Yip VL

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2147/pgpm.s108598

PubMed Identifier: 28203102

Publication URI: http://europepmc.org/abstract/MED/28203102

Type: Journal Article/Review

Volume: 10

Parent Publication: Pharmacogenomics and personalized medicine

ISSN: 1178-7066